Dr. Christina Gutowski, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Camden, NJ 08103 Phone: 856-361-1754 |
Catherine Julia Fedorka, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plaza, Ste 408, Camden, NJ 08103 Phone: 856-342-3162 Fax: 856-968-8661 |
News Archive
A drug approved for the treatment of rheumatoid arthritis may also turn out to be the first targeted therapy for one of the most common forms of kidney disease, a condition that almost inevitably leads to kidney failure.
Entelos, Inc., a simulation and modeling company focused on human health, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,654,955 entitled "Apparatus and Methods for Assessing Metabolic Substrate Utilization" to the Company. These methods further strengthen the Entelos® Metabolism PhysioLab® platform and leverage insights about human physiology that can lead to improved diagnosis, clinical testing, and personalized treatment across a highly variable patient population.
Like most health professionals, David Olson has known for some time of the dangers posed by excessive stress. His latest research, though, is giving surprising new insight into how chronic stress in childhood can have an impact years after it occurred in women giving birth.
A latest study shows that a hormone receptor normally confined to the reproductive organs is found in malignant tumors in many parts of the body. Researchers from the Mt. Sinai School of Medicine in New York City explained that this may mean a new target for the early diagnosis and treatment of cancer. The study was published in the latest issue of The New England Journal of Medicine.
The Muscular Dystrophy Association today heralds a landmark muscular dystrophy advance by an international study team of scientists and physicians from the Netherlands, United States, France and Spain. Led by MDA-grantee Silvère van der Maarel, Ph.D., at Leiden University Medical Center in the Netherlands, the collaborative study of more than 2,300 people found that two distinct genetic changes on chromosome 4 must be present to cause facioscapulohumeral muscular dystrophy (FSHD).
› Verified 8 days ago